Sheeba K. Thomas
- Hematology top 0.5%
- Molecular Biology top 10%
- Oncology top 5%
- Pathology and Forensic Medicine top 5%
- Genetics top 2%
- Co-authors
- Robert Z. OrlowskiJatin J. ShahDonna M. WeberMichael WangRaymond AlexanianMuzaffar H. QazilbashVeerabhadran BaladandayuthapaniNina Shah
- Topics
- Multiple Myeloma Research and Treatments (116 papers)Chronic Lymphocytic Leukemia Research (43 papers)Protein Degradation and Inhibitors (41 papers)
- Cited by
- HematologyGeneticsOncology
- Partner nations
- United StatesChinaGermany
In The Last Decade
Sheeba K. Thomas
151 papers receiving 2.0k citations
Peers
Comparison fields: 5 of 93
- Hematology 1.1k
- Molecular Biology 1.1k
- Oncology 889
- Pathology and Forensic Medicine 392
- Genetics 366
Countries citing papers authored by Sheeba K. Thomas
This map shows the geographic impact of Sheeba K. Thomas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sheeba K. Thomas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sheeba K. Thomas more than expected).
Fields of papers citing papers by Sheeba K. Thomas
This network shows the impact of papers produced by Sheeba K. Thomas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sheeba K. Thomas. The network helps show where Sheeba K. Thomas may publish in the future.
Co-authorship network of co-authors of Sheeba K. Thomas
This figure shows the co-authorship network connecting the top 25 collaborators of Sheeba K. Thomas. A scholar is included among the top collaborators of Sheeba K. Thomas based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sheeba K. Thomas. Sheeba K. Thomas is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 4 | |
| 3 | 1 | |
| 4 | 1 | |
| 5 | 9 | |
| 6 | 1 | |
| 7 | 7 | |
| 8 | 8 | |
| 9 | 0 | |
| 10 | 7 | |
| 11 | 2 | |
| 12 | 4 | |
| 13 | 3 | |
| 14 | 9 | |
| 15 | 14 | |
| 16 | 1 | |
| 17 | 12 | |
| 18 | 16 | |
| 19 | Treatment recommendations for patients with Waldenström macroglobulinemia (WM) and related disorders: IWWM-7 consensus. | 0 |
| 20 | 35 |
About Sheeba K. Thomas
Sheeba K. Thomas is a scholar working on Hematology, Genetics and Oncology, having authored 161 papers that have together received 2.0k indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (116 papers), Chronic Lymphocytic Leukemia Research (43 papers) and Protein Degradation and Inhibitors (41 papers). The work is most often cited by research in Hematology (1.1k citations), Genetics (366 citations) and Oncology (889 citations). Sheeba K. Thomas has collaborated with scholars based in United States, China and Germany. Frequent co-authors include Robert Z. Orlowski, Jatin J. Shah, Donna M. Weber, Michael Wang, Raymond Alexanian, Muzaffar H. Qazilbash, Veerabhadran Baladandayuthapani, Nina Shah, Qaiser Bashir and Elisabet E. Manasanch. Their work appears in journals such as Nature Communications, Journal of Clinical Oncology and Blood.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.